Found 140 matching trials
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM) PHASE1 This multicenter, open-label, Phase I study will evaluate the safety, effic...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study NA This study is looking at outcomes in people with advanced cancers who have ...
Show More Location
Peter MacCallum Cancer Centre
Learn More & Join Trial
Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer PHASE2 This phase II trial studies the effect of lamivudine in combination with st...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
Genetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, Urothelial Cancer, or Non-small Cell Lung Cancer PHASE1 This phase I/II trial investigates the side effects of genetically engineer...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer PHASE1 This clinical trial will be conducted as a single-center, open-label, Phase...
Show More Location
University of Iowa Hospitals and Clinics
Learn More & Join Trial
Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC PHASE1 This phase I trial studies the side effects of atezolizumab, varlilumab, an...
Show More Location
Rutgers Cancer Institute of New Jersey
Learn More & Join Trial
A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study PHASE3 This is an open-label, multicenter, extension study. Patients who are recei...
Show More Status
Active Not Recruiting
Location
University of Colorado Cancer Center
Learn More & Join Trial
Study to Assess AFM24 in Combination With Atezolizumab in Selected Advanced/Metastatic EGFR-expressing Cancers PHASE1 AFM24-102 is a Phase 1/2a open-label, non-randomized, multicenter, dose esc...
Show More Location
USC Norris Comprehensive Cancer Center
Learn More & Join Trial
Combination of Atezolizumab With Dendritic Cell Vaccine in Patients With Lung Cancer PHASE1 This is a single-arm Phase Ib/II multicenter open-label study, with transla...
Show More Learn More & Join Trial
dTACE-HAIC Combined With Bevacizumab and Atezolizumab for Huge Hepatocellular Carcinoma NA This study intends to evaluate the efficacy and safety of drug-eluting tran...
Show More Location
Chinese PLA General hospital
Learn More & Join Trial